Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease

Johanna Lehtomäkia Department of Paediatrics, Tampere University Hospital, Tampere, FinlandView further author information

Anne Nikkonenb University of Helsinki, Children’s Hospital, Helsinki, FinlandView further author information

Laura Merras-Salmiob University of Helsinki, Children’s Hospital, Helsinki, FinlandView further author information

Pauliina Hiltunena Department of Paediatrics, Tampere University Hospital, Tampere, FinlandView further author information

Kaija-Leena Kolhob University of Helsinki, Children’s Hospital, Helsinki, Finland;c Faculty of Medicine and Health Technology, Tampere University, Tampere, FinlandCorrespondence[email protected]

https://orcid.org/0000-0001-9170-8415 View further author information

Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Therapy outcome related to adalimumab trough levels in pediatric patients with inflammatory bowel disease

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date